BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ALX2004 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ALX2004\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07085091-2344@assetmemo.bio
DTSTAMP:20261121T005825Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:ALX2004: Phase 1 readout est. (NCT07085091)
DESCRIPTION:ALX2004\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A First
  in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumo
 rs\nEstimated primary completion: June 2027. This is a ClinicalTrials.gov 
 estimate\, not a confirmed readout date\, and it can move.\nDrug page: htt
 ps://assetmemo.bio/drug/alx2004#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT07085091
URL:https://assetmemo.bio/drug/alx2004#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
